Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
OsteoRemedies, LLC · with MCRA · NCT06428448
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 60
- US sites recruiting
- 3
- Study start
- February 1, 2026
- Record last updated
- May 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is being conducted to evaluate the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the treatment of ankle-related infections. The study is expected to take approximately 18 months from first subject enrolled to the last follow-up visit. It will have a 12-month enrollment period and a 6-month follow-up. This study is a Prospective, multicenter, single-arm clinical trial. All subjects enrolled in this study will receive the REMEDY SPECTRUM IM Spacer Nail.
Being studied: REMEDY Spectrum IM Spacer Nail
Conditions: Periprosthetic Joint Infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Be ≥ 21 years of age
- Have an ankle-related infection
- Is skeletally mature, as evidenced by closed epiphyses.
- Be able to give voluntary, written informed consent to participate and have signed an Informed Consent Form specific to this study
- Be willing and able to comply with all study procedures including all pre-operative, post-operative requirements
- If female and of child-bearing potential, must have a negative pregnancy test prior to the surgical procedure and no intention of becoming pregnant until study completion.
Exclusion Criteria
- Infections that do not involve the ankle
- Have a known immunodeficiency; including subjects who are receiving or have received immunosuppressants, immunostimulating agents or radiation therapy within 6 months prior to surgery
- Affected limb is dysvascular
- Where adequate soft-tissue coverage cannot be achieved
- Have any mental or psychological disorder that would impair their ability to complete the study questionnaires
- Are currently pregnant or breastfeeding, or planning to become pregnant or breastfeed any time during the course of the study
- Are currently a prisoner
- Have any medical condition or other circumstances, in the judgment of the Investigator, that might interfere with the ability to return for follow-up visits, including any systemic illness, neuromuscular, neurosensory, or musculoskeletal deficiency that would render the subject unable to perform appropriate post-operative activities.
- History of vancomycin or gentamicin allergy
- Are implanted with other antibiotic eluting products.
Recruiting US locations
University of Michigan Health - Sparrow Clinical Research Institute
Lansing, MI 48190
Site contact: Jennifer Boak · 517-364-5733 · Jennifer.Boak@UofMHealth.org
OrthoCarolina Research Institute
Charlotte, NC 28207
Site contact: Zachary Hutchko · 704-323-2556 · Zachery.Hutchko@orthocarolina.com
Duke University Medical Center
Durham, NC 27710
Site contact: Caroline Darragh · 919-613-3670 · caroline.darragh@duke.edu
Study contacts (from the official record)
- Crystal Djaba · 470-736-7850 · cdjaba@mcra.com
- Jacob Schafer · jschafer@mcra.com
Similar studies in Michigan
All healthy volunteers studies in Michigan →- RecruitingHealthy volunteers
Tailoring a Home Supervision Intervention for Latinx Caregivers
Western Michigan University
- Location
- Kalamazoo, MI
- Eligibility basics
- Ages 18–99
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- Allen Park, MI + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Ann Arbor, MI + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Prevail Therapeutics
- Location
- Farmington Hills, MI + 1 other US site
- Eligibility basics
- Ages 30–80